A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
Japan's Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ -- Prolacta Bioscience® today announced that Japan's Ministry of Health,...
From Morphology to Clinical Insights: Ozelle's AI-Powered Diagnostics at WHX Labs Dubai 2026
DUBAI, UAE, Feb. 10, 2026 /PRNewswire/ -- As WHX Labs Dubai 2026 opens today, visitors to Booth S1.D58 are invited to see how Ozelle transforms diagnostic testing into interactive, decision-ready workflows. Under the theme "AI × CBM: The...
Infinitus Recognised as a Top Employer in China for 2026 for the Sixth Consecutive Year
GUANGZHOU, China, Jan. 20, 2026 /PRNewswire/ -- Infinitus, a leader in the health and wellness industry, is pleased to announce that it has been recognised as a "Top Employer in China for 2026" by the Top Employers Institute, marking the sixth...
Microsoft Selects Iron Software as Key .NET 10 Launch Partner for APAC Region, Showcasing C# Generate PDF Innovation at .NET Conf Thailand 2025
Iron Software successfully hosted Microsoft-sponsored virtual event, delivering expert insights on .NET 10 migration, AI-powered development, and performance optimization to developers across Asia-Pacific. CHICAGO and CHIANG MAI, Thailand, Dec. 16,...
Noul Supplies AI Diagnostic Platform miLab™ to Charité, Europe's Leading University Hospital
Prestigious Nobel Prize–winning institution confirms adoption of miLab™ following clinical evaluation "A milestone signaling broader adoption in advanced global healthcare markets" YONGIN, South Korea, Oct. 28, 2025 /PRNewswire/ -- Noul Co.,...
InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025
NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; NCT05379946)...
ValueLabs Wins Nine Globee® Awards, Validates Position as Agentic AI Services Leader
HYDERABAD, India, May 26, 2025 /PRNewswire/ -- ValueLabs has been recognized at the 2025 Globee® Awards for Artificial Intelligence, winning eight Gold and one Bronze awards across key categories. This recognition reinforces the company's position...
TencentDB TDStore Online DDL: Technological Evolution and Innovations Background & Challenges
SHENZHEN, China, April 22, 2025 /PRNewswire/ -- Traditional single-node databases (e.g., MySQL) use OnlineDDL and third-party tools (e.g., pt-osc) to enable lock-free schema changes, but face performance bottlenecks and struggle in distributed...
Pioneering in Intelligent Acoustic Manufacturing: Decoding Tiinlab's Core ODM Competitiveness
SHENZHEN, China, April 17, 2025 /PRNewswire/ -- As global supply chains undergo rapid restructuring, 1MORE's parent company, Tiinlab Corporation, is redefining the standard for intelligent acoustic manufacturing. With a vertically integrated,...
SenseiNode Achieves ISO 27001 Certification For Information Security Excellence
BUENOS AIRES, Argentina, April 14, 2025 /PRNewswire/ -- SenseiNode, the leading blockchain infrastructure provider in Latin America, has successfully completed the ISO 27001:2022 certification process, the global standard for information security...